Literature DB >> 14504269

ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion.

Gregory A Graf1, Liqing Yu, Wei-Ping Li, Robert Gerard, Pamela L Tuma, Jonathan C Cohen, Helen H Hobbs.   

Abstract

ABCG5 (G5) and ABCG8 (G8) are ATP-binding cassette (ABC) transporters that limit intestinal absorption and promote biliary excretion of neutral sterols. Mutations in either ABCG5 or ABCG8 result in an identical clinical phenotype, suggesting that these two half-transporters function as heterodimers. Expression of both G5 and G8 is required for either protein to be transported to the plasma membrane of cultured cells. In this paper we used immunofluorescence microscopy to confirm, in vivo, that G5 is localized to the apical membranes of mouse enterocytes and hepatocytes. Other ABC half-transporters function as homodimers or as heterodimers with other subfamily members. To determine whether G5 or G8 complex with other ABCG half-transporters, we co-expressed G1, G2, and G4 with either G5 or G8 in cultured cells. G1, G2, and G4 co-immunoprecipitated with G5, and G4 co-immunoprecipitated with G8, but the putative dimers were retained in the endoplasmic reticulum (ER). Adenovirus-mediated expression of either G5 or G8 in the liver of G5G8 null mice resulted in ER retention of the expressed proteins and no increase in biliary cholesterol. In contrast, co-expression of G5 and G8 resulted in transit of the proteins out of the ER and a 10-fold increase in biliary cholesterol concentration. Finally, adenoviral expression of G2 in the presence or absence of G5 or G8 failed to promote sterol excretion into bile. These experiments indicate that G5 and G8 function as obligate heterodimers to promote sterol excretion into bile.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504269     DOI: 10.1074/jbc.M310223200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  155 in total

Review 1.  Moving out: from sterol transport to drug resistance - the ABCG subfamily of efflux pumps.

Authors:  Karobi Moitra; Latoya Silverton; Katy Limpert; Kate Im; Michael Dean
Journal:  Drug Metabol Drug Interact       Date:  2011-09-27

2.  Intragenic suppressing mutations correct the folding and intracellular traffic of misfolded mutants of Yor1p, a eukaryotic drug transporter.

Authors:  Silvere Pagant; John J Halliday; Christos Kougentakis; Elizabeth A Miller
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

Review 3.  ABCG5/G8 polymorphisms and markers of cholesterol metabolism: systematic review and meta-analysis.

Authors:  Lily Jakulj; Maud N Vissers; Michael W T Tanck; Barbara A Hutten; Frans Stellaard; John J P Kastelein; Geesje M Dallinga-Thie
Journal:  J Lipid Res       Date:  2010-06-25       Impact factor: 5.922

Review 4.  A new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport.

Authors:  Ryan-E Temel; J-Mark Brown
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

Review 5.  ABC transporters and their role in nucleoside and nucleotide drug resistance.

Authors:  Yu Fukuda; John D Schuetz
Journal:  Biochem Pharmacol       Date:  2012-01-20       Impact factor: 5.858

6.  Opposing Gatekeepers of Apical Sterol Transport: Niemann-Pick C1-Like 1 (NPC1L1) and ATP-Binding Cassette Transporters G5 and G8 (ABCG5/ABCG8).

Authors:  J Mark Brown; Liqing Yu
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2009-03

7.  Molecular expression and functional evidence of a drug efflux pump (BCRP) in human corneal epithelial cells.

Authors:  Pradeep K Karla; Ravinder Earla; Sagar H Boddu; Thomas P Johnston; Dhananjay Pal; Ashim Mitra
Journal:  Curr Eye Res       Date:  2009-01       Impact factor: 2.424

8.  Phytosterol feeding causes toxicity in ABCG5/G8 knockout mice.

Authors:  Allison L McDaniel; Heather M Alger; Janet K Sawyer; Kathryn L Kelley; Nancy D Kock; J Mark Brown; Ryan E Temel; Lawrence L Rudel
Journal:  Am J Pathol       Date:  2013-02-01       Impact factor: 4.307

Review 9.  ABCG transporters: structure, substrate specificities and physiological roles : a brief overview.

Authors:  Saroj Velamakanni; Shen L Wei; Tavan Janvilisri; Hendrik W van Veen
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

Review 10.  ABCG5 and ABCG8: more than a defense against xenosterols.

Authors:  Shailendra B Patel; Gregory A Graf; Ryan E Temel
Journal:  J Lipid Res       Date:  2018-05-04       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.